SEEL
Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL
Delisted
SEEL was delisted on the 15th of October, 2024.
65 hedge funds and large institutions have $21.3M invested in Seelos Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
35% less capital invested
Capital invested by funds: $33M → $21.3M (-$11.7M)
Holders
65
Holding in Top 10
–
Calls
$799K
Puts
$79K
Top Buyers
| 1 | +$934K | |
| 2 | +$637K | |
| 3 | +$578K | |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$437K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$426K |
Top Sellers
| 1 | -$3.08M | |
| 2 | -$1.12M | |
| 3 | -$971K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$494K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$461K |